BREAKING NEWS
This content is not available in your region

Germany's Merck sees boost from labs supplies earnings

Access to the comments Comments
Germany's Merck sees boost from labs supplies earnings
Germany's Merck sees boost from labs supplies earnings   -   Copyright  (c) Copyright Thomson Reuters 2021. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Text size Aa Aa

FRANKFURT (Reuters) – Germany’s Merck on Wednesday said its Life Science business, a leading maker of biotech lab supplies and gear, saw core earnings jump more than 43% in the first quarter, driven by the pharma industry’s efforts to fight the coronavirus pandemic.

Adjusted earnings before interest, tax, depreciation and amortization at the division rose to 793 million euros ($961 million).

The company, which also makes pharmaceuticals and specialty chemicals, on May 4 reported better-than-expected quarterly earnings for the group ahead of schedule.

At the time it said it expected 2021 adjusted earnings before interest, tax, depreciation and amortization (EBITDA) of 5.4-5.8 billion euros, up from 5.2 billion last year. It reaffirmed that guidance on Wednesday.

(Reporting by Ludwig Burger; Editing by Riham Alkousaa)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.